Moreover, in bladder cancer, it has been reported that miR-200c is downregulated in cancer specimens compared with adjacent tissues in the same patients [14], and miR-200c could inhibit bladder cancer cell invasion through direct targeting of BMI-1 and E2F3. This evidence concerns the gene E2F3 and urinary bladder carcinoma.